The company encountered some difficulties last year, but following the spinoff of its healthcare division, it appears to be on the path to recovery.
Keep Reading →
July 15 - News
[caption id="attachment_1196393" align="aligncenter" width="1456"] A shot of a commercial plane with a blur of color in the background, representing the production of auxiliary...
Keep Reading →
July 15 - News
The company has paid regular dividends to shareholders for 125 years in a row and has raised its payouts for 18 consecutive years.
Keep Reading →
July 15 - News
Headwaters Capital Management, an investment management company, released its second-quarter 2025 investor letter.
Keep Reading →
July 15 - Hedge Fund Investor Letters, News
Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
July 15 - Hedge Fund Investor Letters, News
Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
July 15 - Hedge Fund Investor Letters, News
Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
July 15 - Hedge Fund Investor Letters, News
Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
July 15 - Hedge Fund Investor Letters, News
Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
July 15 - Hedge Fund Investor Letters, News
Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
July 15 - Hedge Fund Investor Letters, News
Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
July 15 - Hedge Fund Investor Letters, News
Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
July 15 - Hedge Fund Investor Letters, News
Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
July 15 - Hedge Fund Investor Letters, News
Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
July 15 - Hedge Fund Investor Letters, News
Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter.
Keep Reading →
July 15 - Hedge Fund Investor Letters, News
Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” second quarter 2025 investor letter.
Keep Reading →
July 15 - Hedge Fund Investor Letters, News
Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” second quarter 2025 investor letter.
Keep Reading →
July 15 - Hedge Fund Investor Letters, News
Traders often measure success by outcomes, but what consistently influences those outcomes is the structure of trading costs.
Keep Reading →
July 15 - Business, News
BloomZ Inc. (NASDAQ:BLMZ) is one of the 13 Best Japanese Stocks to Buy According to Hedge Funds. On May 22, BloomZ Inc.
Keep Reading →
July 15 - News
Tokyo Lifestyle Co., Ltd. (NASDAQ:TKLF) is one of the 13 Best Japanese Stocks to Buy According to Hedge Funds. On June 26, Tokyo Lifestyle Co., Ltd.
Keep Reading →
July 15 - News
Lead Real Estate Co., Ltd (NASDAQ:LRE) is one of the 13 Best Japanese Stocks to Buy According to Hedge Funds. On July 10, Lead Real Estate Co., Ltd.
Keep Reading →
July 15 - News
HeartCore Enterprises, Inc. (NASDAQ:HTCR) is one of the 13 Best Japanese Stocks to Buy According to Hedge Funds. On July 2, HeartCore Enterprises, Inc.
Keep Reading →
July 15 - News
ORIX Corporation (NYSE:IX) is one of the 13 Best Japanese Stocks to Buy According to Hedge Funds.
Keep Reading →
July 15 - News
Nomura Holdings, Inc. (NYSE:NMR) is one of the 13 Best Japanese Stocks to Buy According to Hedge Funds. On June 25, Nomura Holdings, Inc.
Keep Reading →
July 15 - News
Honda Motor Co., Ltd. (NYSE:HMC) is one of the 13 Best Japanese Stocks to Buy According to Hedge Funds. On June 26, Honda Motor Co., Ltd.
Keep Reading →
July 15 - News
Mizuho Financial Group, Inc. (NYSE:MFG) is one of the 13 Best Japanese Stocks to Buy According to Hedge Funds. On May 20, Mizuho Financial Group, Inc.
Keep Reading →
July 15 - News
Mitsubishi UFJ Financial Group, Inc. (NYSE:MUFG) is one of the 13 Best Japanese Stocks to Buy According to Hedge Funds. On May 19, Mitsubishi UFJ Financial Group, Inc.
Keep Reading →
July 15 - News
Sumitomo Mitsui Financial Group, Inc. (NYSE:SMFG) is one of the 13 Best Japanese Stocks to Buy According to Hedge Funds. On July 8, Sumitomo Mitsui Financial Group, Inc.
Keep Reading →
July 15 - News
Toyota Motor Corporation (NYSE:TM) is one of the 13 Best Japanese Stocks to Buy According to Hedge Funds.
Keep Reading →
July 15 - News
Takeda Pharmaceutical Company Limited (NYSE:TAK) is one of the 13 Best Japanese Stocks to Buy According to Hedge Funds.
Keep Reading →
July 15 - News
Sony Group Corporation (NYSE:SONY) is one of the 13 Best Japanese Stocks to Buy According to Hedge Funds.
Keep Reading →
July 15 - News
Gilead Sciences, Inc. (NASDAQ:GILD) is one of Goldman Sachs’ top healthcare stock picks.
Keep Reading →
July 15 - News
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of Goldman Sachs’ top healthcare stock picks.
Keep Reading →
July 15 - News
AstraZeneca PLC (NASDAQ:AZN) is one of Goldman Sachs’ top healthcare stock picks. On July 4, the company secured regulatory approval for Imfinzi (durvalumab).
Keep Reading →
July 15 - News
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of Goldman Sachs’ top healthcare stock picks.
Keep Reading →
July 15 - News
Intuitive Surgical Inc. (NASDAQ:ISRG) is one of Goldman Sachs’ top healthcare stock picks.
Keep Reading →
July 15 - News
Boston Scientific Corporation (NYSE:BSX) is one of Goldman Sachs’ top healthcare stock picks.
Keep Reading →
July 15 - News
Johnson & Johnson (NYSE:JNJ) is one of Goldman Sachs’ top healthcare stock picks.
Keep Reading →
July 15 - News
AbbVie Inc. (NYSE:ABBV) is one of Goldman Sachs’ top healthcare stock picks.
Keep Reading →
July 15 - News
UnitedHealth Group Incorporated (NYSE:UNH) is one of Goldman Sachs’ top healthcare stock picks.
Keep Reading →
July 15 - News
Eli Lilly and Company (NYSE:LLY) is one of Goldman Sachs’ top healthcare stock picks.
Keep Reading →
July 15 - News
According to a report by Mordor Intelligence, the medical device industry is valued at $681.57 billion as of 2025.
Keep Reading →
July 15 - Hedge Funds, News
Viatris Inc. (NASDAQ:VTRS) is one of the best low priced pharma stocks to buy now.
Keep Reading →
July 15 - News
Aclaris Therapeutics Inc. (NASDAQ:ACRS) is one of the best low priced pharma stocks to buy now.
Keep Reading →
July 15 - News
Arvinas Inc. (NASDAQ:ARVN) is one of the best low priced pharma stocks to buy now.
Keep Reading →
July 15 - News
Biohaven Ltd. (NYSE:BHVN) is one of the best low priced pharma stocks to buy now.
Keep Reading →
July 15 - News
Wave Life Sciences Ltd. (NASDAQ:WVE) is one of the best low priced pharma stocks to buy now.
Keep Reading →
July 15 - News
Liquidia Corporation (NASDAQ:LQDA) is one of the best low priced pharma stocks to buy now.
Keep Reading →
July 15 - News
Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) is one of the best low priced pharma stocks to buy now.
Keep Reading →
July 15 - News
Viridian Therapeutics Inc. (NASDAQ:VRDN) is one of the best low priced pharma stocks to buy now.
Keep Reading →
July 15 - News